ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
디지털 게놈 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에는 CAGR 19.9%를 나타내 966억 5,000만 달러로 성장할 전망입니다. 예측 기간의 성장은 유전성 질환의 유병률 증가, 디지털 게놈에 대한 연구개발 증가, 맞춤형 의료 채용 확대, 생명공학 발전, 만성질환 유병률 증가 등에 기인합니다. 예측 기간의 주요 동향으로는 차세대 시퀀싱기술의 채용 증가, 기술진보 증가, 진단산업에서의 미생물의 광범위한 이용, 개별화의료에 대한 수요 증가, 병원 및 진료소에서의 디지털 게놈 기술의 채용 증가 등을 들 수 있습니다.
향후 5년간의 성장률 19.9%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭의 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 영국과 한국에서 조달하는 차세대 시퀀싱(NGS) 시스템과 유전체 분석 소프트웨어의 비용을 상승시키고, 맞춤형 의료의 도입을 늦추고, 분자진단의 지출을 증가시킴으로써 미국을 저해할 것으로 예측됩니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.
유전성 질환의 유병률 증가는 디지털 게놈 시장 전망 성장을 가속할 것으로 예측됩니다. 유전성 질환은 개인의 DNA의 이상이나 돌연변이에 의해 유발되는 유전성 질환으로, 신체의 개발과 기능의 지시를 전달하는 유전 물질입니다. 디지털 게놈 기술은 유전성 질환과 관련된 유전자 돌연변이 및 돌연변이의 확인을 가능하게 합니다. 이 정보는 이러한 질병의 정확하고 조기 진단에 도움이 되며 적시에 개입과 치료를 가능하게합니다. 예를 들어 2023년 8월 미국 의학 도서관인 국립 의학 도서관에 따르면, 겸상 적혈구 빈혈은 미국 아프리카계 미국인의 약 500명 중 한 명이 병을 앓고 있는 유전병입니다. 또한, 아프리카계 미국인의 약 12명 중 1명이 이 질병의 원인이 되는 상염색체 열성 돌연변이를 갖고 있으며, 연간 약 30만명의 유아가 겸상 적혈구 빈혈로 태어나고 있습니다. 따라서 유전성 질환의 유병률 증가는 디지털 게놈 시장 성장을 이끌고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 디지털 게놈 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 디지털 게놈 시장 : 성장률 분석
세계의 디지털 게놈 시장 실적 : 규모와 성장(2019-2024년)
세계의 디지털 게놈 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 디지털 게놈 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 디지털 게놈 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
시퀀싱 및 분석기 기기
데이터 분석 및 관리 도구
세계의 디지털 게놈 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
진단
농업 및 동물 연구
맞춤형 의학
신약 개발
치료 분석
세계의 디지털 게놈 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
연구 센터 및 정부 기관
학술 기관
제약 및 생명공학 산업
병원
진단센터
세계의 디지털 게놈 시장 : 시퀀싱 및 분석기 기기 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
차세대 시퀀싱(NGS) 시스템
샌저 시퀀싱 시스템
단일 세포 시퀀싱 기기
3세대 시퀀싱 기기
세계의 디지털 게놈 시장 : 데이터 분석 및 관리 도구 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
바이오인포매틱스 소프트웨어
데이터 관리 플랫폼
클라우드 기반 분석 솔루션
워크플로우 관리 도구
제7장 지역별/국가별 분석
세계의 디지털 게놈 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 디지털 게놈 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
디지털 게놈 시장 : 경쟁 구도
디지털 게놈 시장 : 기업 프로파일
Roche Holding AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
GE HealthCare Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Quest Diagnostics : 개요, 제품 및 서비스, 전략 및 재무 분석
Eurofins Scientific SE : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Agilent Technologies Inc.
Illumina Inc.
bioMerieux SA
PerkinElmer Inc.
Bio-Rad Laboratories Inc.
Qiagen NV
BGI Genomics
Myriad Genetics Inc.
Foundation Medicine Inc.
ArcherDx Inc.
Invitae Corporation
Oxford Nanopore Technologies Ltd.
Luminex Corporation
GenMark Diagnostics Inc.
NanoString Technologies Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
디지털 게놈 시장(2029년) : 새로운 기회를 제공하는 국가
디지털 게놈 시장(2029년) : 새로운 기회를 제공하는 부문
디지털 게놈 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
The digital genome refers to the digitized and organized collection of an organism's genetic material, including its DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) sequences. This digital representation allows for storing, analyzing, and interpreting genetic information using computational tools and technologies. Digital genomes are essential for understanding genetic variations, disease mechanisms, and evolutionary relationships.
The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The main types of digital genome are sequencing and analyzer instruments, and data analysis and management tools. Sequencing and analyzer instruments refer to equipment used in genomic sequencing and analysis processes, which are essential for decoding the genetic information contained within DNA and RNA molecules. They are used for various applications such as diagnostics, agriculture and animal research, personalized medicine, drug discovery, and treatment analysis by research centers and government institutes, academic institutions, pharmaceutical and biotechnology industries, hospitals, and diagnostic centers.
The digital genome market size has grown rapidly in recent years. It will grow from $39.25 billion in 2024 to $46.82 billion in 2025 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to growing funding for genomics, reduced cost and high speed of DNA sequencing, entry of new players and start-ups in developing economies, increasing number of drug discoveries, and growing biotech sector.
The digital genome market size is expected to see rapid growth in the next few years. It will grow to $96.65 billion in 2029 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to increasing prevalence of genetic disorders, increasing research and development pertaining to digital genome, growing adoption of personalized medicine, developments in biotechnology, and rising prevalence of chronic diseases. Major trends in the forecast period include the increasing adoption of next-generation sequencing technologies, increasing technological advancements, extensive use of microorganisms in diagnostics industry, increasing demand for personalized medicines, and rising adoption of digital genomic technology by hospitals and clinics.
The forecast of 19.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of next-generation sequencing (NGS) systems and genomic analysis software sourced from the UK and South Korea, thereby delaying personalized medicine adoption and elevating molecular diagnostics expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing prevalence of genetic disorders is expected to propel the growth of the digital genome market going forward. Genetic disorders are hereditary conditions caused by abnormalities or mutations in an individual's DNA, the genetic material that carries instructions for the development and functioning of the body. Digital genome technologies enable the identification of genetic mutations and variations associated with genetic disorders. This information helps in accurate and early diagnosis of these disorders, allowing for timely intervention and treatment. For instance, in August 2023, according to the National Library of Medicine, a US-based medical library, sickle cell anemia is a genetic disease that affects approximately 1 in 500 African Americans in the United States. Further, about 1 in 12 African Americans carries the autosomal recessive mutation responsible for the disease, and approximately 300,000 infants are born with sickle cell anemia annually. Therefore, the increasing prevalence of genetic disorders is driving the growth of the digital genome market.
Major companies operating in the digital genome market are developing innovative products such as the NovaSeq X Series to understand disease and ultimately transform patient lives. NovaSeq X Series includes the NovaSeq X and NovaSeq X Plus systems, with the NovaSeq X Plus capable of sequencing more than 128 genomes per run and generating more than 20,000 whole genomes per year. For instance, in September 2022, Illumina, Inc., a US-based biotechnology company, launched the NovaSeq X Series, a significant advancement in whole-genome sequencing technology. The system incorporates cost-efficiency throughout the workflow, streamlined informatics, operational simplicity, sustainability advancements, and world-class support. It also enables broader and deeper sequencing, allowing users to scale up any application to include more samples and analyze data more efficiently. The NovaSeq X Series is designed to be the most potent and cost-effective sequencing system, with improved reagent stability and faster data transfers due to optimized genomics data compression. The system was purpose-built for improved sustainability, with a smaller data footprint that reduces storage and energy consumption costs.
In January 2023, Agilent Technologies, a US-based company specializing in analytical solutions, acquired Avida Biomed for an undisclosed amount. This acquisition is aimed at strengthening Agilent Technologies' next-generation sequencing capabilities by incorporating Avida Biomed's target enrichment workflows. Avida Biomed is a US-based life sciences company that specializes in developing advanced target enrichment workflows for next-generation sequencing (NGS).
Major companies operating in the digital genome market are Roche Holding AG, Thermo Fisher Scientific Inc., GE HealthCare Technologies Inc., Quest Diagnostics, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., bioMerieux SA, PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V., BGI Genomics, Myriad Genetics Inc., Foundation Medicine Inc., ArcherDx Inc., Invitae Corporation, Oxford Nanopore Technologies Ltd., Luminex Corporation, GenMark Diagnostics Inc., NanoString Technologies Inc., Pacific Biosciences of California Inc., Genewiz, Inscripta Inc., Genomic Health Inc., Becton Dickinson and Company, GenomeMe, Regeneron Pharmaceuticals Inc.
North America was the largest region in the digital genome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital genome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital genome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital genome market consists of revenues earned by entities by providing services such as DNA (deoxyribonucleic acid) and RNA (ribonucleic acid) isolation, profiling, qPCR, next-generation sequencing, and advanced bioinformatics data analysis pipelines. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital genome market also includes sales of sequencing and analyzer instruments, sequencing chips, sample preparation instruments, and sequencing and analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Genome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on digital genome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for digital genome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital genome market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Sequencing And Analyzer Instruments; Data Analysis And Management Tools
2) By Application: Diagnostics; Agriculture And Animal Research; Personalized Medicine; Drug Discovery; Treatment Analysis
3) By End User: Research Centers And Government Institutes; Academic Institutions; Pharmaceutical And Biotechnology Industries; Hospitals; Diagnostic Centers
Subsegments:
1) By Sequencing And Analyzer Instruments: Next-Generation Sequencing (NGS) Systems; Sanger Sequencing Systems; Single-Cell Sequencing Instruments; Third-Generation Sequencing Instruments
2) By Data Analysis And Management Tools: Bioinformatics Software; Data Management Platforms; Cloud-Based Analysis Solutions; Workflow Management Tools
Companies Mentioned: Roche Holding AG; Thermo Fisher Scientific Inc.; GE HealthCare Technologies Inc.; Quest Diagnostics; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; bioMerieux SA; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; BGI Genomics; Myriad Genetics Inc.; Foundation Medicine Inc.; ArcherDx Inc.; Invitae Corporation; Oxford Nanopore Technologies Ltd.; Luminex Corporation; GenMark Diagnostics Inc.; NanoString Technologies Inc.; Pacific Biosciences of California Inc.; Genewiz; Inscripta Inc.; Genomic Health Inc.; Becton Dickinson and Company; GenomeMe; Regeneron Pharmaceuticals Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Digital Genome Market Characteristics
3. Digital Genome Market Trends And Strategies
4. Digital Genome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Digital Genome Growth Analysis And Strategic Analysis Framework
5.1. Global Digital Genome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Digital Genome Market Growth Rate Analysis
5.4. Global Digital Genome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Digital Genome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Digital Genome Total Addressable Market (TAM)
6. Digital Genome Market Segmentation
6.1. Global Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing And Analyzer Instruments
Data Analysis And Management Tools
6.2. Global Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Agriculture And Animal Research
Personalized Medicine
Drug Discovery
Treatment Analysis
6.3. Global Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Research Centers And Government Institutes
Academic Institutions
Pharmaceutical And Biotechnology Industries
Hospitals
Diagnostic Centers
6.4. Global Digital Genome Market, Sub-Segmentation Of Sequencing And Analyzer Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS) Systems
Sanger Sequencing Systems
Single-Cell Sequencing Instruments
Third-Generation Sequencing Instruments
6.5. Global Digital Genome Market, Sub-Segmentation Of Data Analysis And Management Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioinformatics Software
Data Management Platforms
Cloud-Based Analysis Solutions
Workflow Management Tools
7. Digital Genome Market Regional And Country Analysis
7.1. Global Digital Genome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Digital Genome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Digital Genome Market
8.1. Asia-Pacific Digital Genome Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Digital Genome Market
9.1. China Digital Genome Market Overview
9.2. China Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Digital Genome Market
10.1. India Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Digital Genome Market
11.1. Japan Digital Genome Market Overview
11.2. Japan Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Digital Genome Market
12.1. Australia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Digital Genome Market
13.1. Indonesia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Digital Genome Market
14.1. South Korea Digital Genome Market Overview
14.2. South Korea Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Digital Genome Market
15.1. Western Europe Digital Genome Market Overview
15.2. Western Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Digital Genome Market
16.1. UK Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Digital Genome Market
17.1. Germany Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Digital Genome Market
18.1. France Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Digital Genome Market
19.1. Italy Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Digital Genome Market
20.1. Spain Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Digital Genome Market
21.1. Eastern Europe Digital Genome Market Overview
21.2. Eastern Europe Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Digital Genome Market
22.1. Russia Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Digital Genome Market
23.1. North America Digital Genome Market Overview
23.2. North America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Digital Genome Market
24.1. USA Digital Genome Market Overview
24.2. USA Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Digital Genome Market
25.1. Canada Digital Genome Market Overview
25.2. Canada Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Digital Genome Market
26.1. South America Digital Genome Market Overview
26.2. South America Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Digital Genome Market
27.1. Brazil Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Digital Genome Market
28.1. Middle East Digital Genome Market Overview
28.2. Middle East Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Digital Genome Market
29.1. Africa Digital Genome Market Overview
29.2. Africa Digital Genome Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Digital Genome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Digital Genome Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Digital Genome Market Competitive Landscape And Company Profiles
30.1. Digital Genome Market Competitive Landscape
30.2. Digital Genome Market Company Profiles
30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. GE HealthCare Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
31. Digital Genome Market Other Major And Innovative Companies
31.1. Agilent Technologies Inc.
31.2. Illumina Inc.
31.3. bioMerieux SA
31.4. PerkinElmer Inc.
31.5. Bio-Rad Laboratories Inc.
31.6. Qiagen N.V.
31.7. BGI Genomics
31.8. Myriad Genetics Inc.
31.9. Foundation Medicine Inc.
31.10. ArcherDx Inc.
31.11. Invitae Corporation
31.12. Oxford Nanopore Technologies Ltd.
31.13. Luminex Corporation
31.14. GenMark Diagnostics Inc.
31.15. NanoString Technologies Inc.
32. Global Digital Genome Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Digital Genome Market
34. Recent Developments In The Digital Genome Market
35. Digital Genome Market High Potential Countries, Segments and Strategies
35.1 Digital Genome Market In 2029 - Countries Offering Most New Opportunities
35.2 Digital Genome Market In 2029 - Segments Offering Most New Opportunities
35.3 Digital Genome Market In 2029 - Growth Strategies
